Predicting stroke through genetic risk functions the CHARGE risk score project

Stroke

Volumn 45, Issue 2, 2014, Pages 403-412

  Ibrahim Verbaas, Carla A ^a,b   Fornage, Myriam ^c,d   Bis, Joshua C ^e,f   Choi, Seung Hoan ^h,i,j   Psaty, Bruce M ^e,f,g   Meigs, James B ^k   Rao, Madhu ^l   Nalls, Mike ^m   Fontes, Joao D ^i,j   O'Donnell, Christopher J ^j   Kathiresan, Sekar ^k,n   Ehret, Georg B ^o,p,q   Fox, Caroline S ^j,r,s   Malik, Rainer ^t   Dichgans, Martin ^t   Schmidt, Helena ^u   Lahti, Jari ^v,w   Heckbert, Susan R ^f   Lumley, Thomas ^x   Rice, Kenneth ^f   Rotter, Jerome I ^y   Taylor, Kent D ^y   Folsom, Aaron R ^z   Boerwinkle, Eric ^d   Rosamond, Wayne D ^aa   Shahar, Eyal ^ab   Gottesman, Rebecca F ^o   Koudstaal, Peter J ^a   Amin, Najaf ^a,b   Wieberdink, Renske G ^a   Dehghan, Abbas ^a   Hofman, Albert ^a,ac   Uitterlinden, André G ^a,ac   DeStefano, Anita L ^h,i   Debette, Stephanie ^{h,i,j,ad,ae,af}   Xue, Luting ^h,i,j   Beiser, Alexa ^h,i,j   Wolf, Philip A ^h,i,j   DeCarli, Charles ^ag   Ikram, M Arfan ^a,ac   Seshadri, Sudha ^i,j   Mosley, Thomas H ^ah   Longstreth, W T ^f   Van Duijn, Cornelia M ^a,b,ac   Launer, Lenore J ^m   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Center of Medical Systems Biology   (Netherlands)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g CENTER FOR HEALTH STUDIES   (United States)

^h BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j FRAMINGHAM HEART STUDY   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NATIONAL INSTITUTE ON AGING   (United States)

ⁿ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^o JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF LAUSANNE   (Switzerland)

^q GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^r NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^s HARVARD MEDICAL SCHOOL   (United States)

^t LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^u MEDICAL UNIVERSITY OF GRAZ   (Austria)

^v UNIVERSITY OF HELSINKI   (Finland)

^w FOLKHÄLSAN RESEARCH CENTER   (Finland)

^x UNIVERSITY OF AUCKLAND   (New Zealand)

^y CEDARS SINAI MEDICAL CENTER   (United States)

^z UNIVERSITY OF MINNESOTA   (United States)

^aa University of North Carolina at Chapel Hill   (United States)

^ab UNIVERSITY OF ARIZONA   (United States)

^ac Netherlands Consortium for Healthy Ageing   (Netherlands)

^ad LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^ae HÔPITAL LARIBOISIÈRE   (France)

^af INSERM   (France)

^ag UNIVERSITY OF CALIFORNIA   (United States)

^ah UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

more..

Author keywords

Genetic epidemiology; Risk factors; Stroke

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FIBRINOGEN; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRAIN ISCHEMIA; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; END STAGE RENAL DISEASE; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; FRAMINGHAM STROKE RISK SCORE; GENDER; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT; POPULATION RESEARCH; PR INTERVAL; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; RISK ASSESSMENT; RR INTERVAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

GENETIC EPIDEMIOLOGY; RISK FACTORS; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE; SEX FACTORS; STROKE;

EID: 84893783009     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.003044     Document Type: Article

References (32)

1. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76(6 suppl):S85-S90.
2. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6:182-187.
3. Bak S, Gaist D, Sindrup SH, Skytthe A, Christensen K. Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke. 2002;33:769-774.
4. Bevan S, Traylor M, Adib-Samii P, Malik R, Paul NL, Jackson C, et al. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke. 2012;43:3161-3167.
5. International Stroke Genetics Consortium (ISGC), Wellcome Trust Case Control Consortium 2 (WTCCC2), Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, et al. Genome-wide association study identifies a variant in hdac9 associated with large vessel ischemic stroke. Nat Genet. 2012;44:328-333.
6. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng YC, et al; Australian Stroke Genetics Collaborative, Wellcome Trust Case Control Consortium 2 (WTCCC2); International Stroke Genetics Consortium. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11:951-962.
7. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, et al. Genomewide association studies of stroke. N Engl J Med. 2009;360:1718-1728.
8. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
9. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25:40-43.
10. Wassertheil-Smoller S, McGinn A, Allison M, Ca T, Curb D, Eaton C, et al. Improvement in stroke risk prediction: role of c-reactive protein and lipoprotein-associated phospholipase A2 in the women's health initiative. Int J Stroke. October 23, 2012. doi: 10.1111/j.1747- 4949.2012.00860.x.: http://www.ncbi.nlm.nih.gov/pubmed/23088183. Accessed April 23, 2013.
11. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008;358:1240-1249.
12. Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al; CHARGE Consortium. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2:73-80.
13. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129:687-702.
14. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
15. Dawber TR, Kannel WB. The Framingham study. An epidemiological approach to coronary heart disease. Circulation. 1966;34:553-555.
16. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study. Design and preliminary data. Prev Med. 1975;4:518-525.
17. Hofman A, Breteler MM, van Duijn CM, Janssen HL, Krestin GP, Kuipers EJ, et al. The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol. 2009;24:553-572.
18. Marroni F, Pfeufer A, Aulchenko YS, Franklin CS, Isaacs A, Pichler I, et al; EUROSPAN Consortium. A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project. Circ Cardiovasc Genet. 2009;2:322-328.
19. Dehghan A, Yang Q, Peters A, Basu S, Bis JC, Rudnicka AR, et al; Wellcome Trust Case Control Consortium. Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet. 2009;2:125-133.
20. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
21. Laliberté E. Metacor: Meta-analysis of correlation coefficients. R package version 1.0-2. 2011. http://CRAN.R-project.org/package=metacor. Accessed April 19, 2012.
22. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21.
23. Pencina MJ, D'Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med. 2012;31:101-113.
24. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-10.
25. Wain LV, Verwoert GC, O'Reilly PF, Shi G, Johnson T, Johnson AD, et al; LifeLines Cohort Study; EchoGen consortium; AortaGen Consortium; CHARGE Consortium Heart Failure Working Group; KidneyGen consortium; CKDGen consortium; Cardiogenics consortium; CardioGram. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet. 2011;43: 1005-1011.
26. Paynter NP, Chasman DI, Paré G, Buring JE, Cook NR, Miletich JP, et al. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA. 2010;303:631-637.
27. Brautbar A, Pompeii LA, Dehghan A, Ngwa JS, Nambi V, Virani SS, et al. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012;223:421-426.
28. Hernesniemi JA, Seppälä I, Lyytikäinen LP, Mononen N, Oksala N, Hutri-Kähönen N, et al. Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey-a metaanalysis of three independent studies. PLoS One. 2012;7:e28931.
29. Yiannakouris N, Katsoulis M, Dilis V, Parnell LD, Trichopoulos D, Ordovas JM, et al. Genetic predisposition to coronary heart disease and stroke using an additive genetic risk score: a population-based study in Greece. Atherosclerosis. 2012;222:175-179.
30. Havulinna AS, Kettunen J, Ukkola O, Osmond C, Eriksson JG, Kesäniemi YA, et al. A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension. 2013;61:987-994.
31. Kerr KF, McClelland RL, Brown ER, Lumley T. Evaluating the incremental value of new biomarkers with integrated discrimination improvement. Am J Epidemiol. 2011;174:364-374.
32. Hilden J, Gerds TA. A note on the evaluation of novel biomarkers: Do not rely on integrated discrimination improvement and net reclassification index. Stat Med. April 2, 2013. doi: 10.1002/sim.5804.: http://www.ncbi. nlm.nih.gov/pubmed/23553436. Accessed April 10, 2013.